SAN DIEGO, Oct. 4, 2023 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that its Board of Directors has approved a 1-for-10 reverse stock split of the Company's common stock, effective at 5:00 p.m. ET on October 4, 2023. The Company's shares of common stock will begin trading on a reverse split-adjusted basis commencing upon market opening on October 5, 2023.
Read more at prnewswire.comAethlon Announces Reverse Stock Split
PR Newswire -
Wed Oct 4, 2023
Columnist
Contributor Content
Press Release
Sponsored Content
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/Tesla%20charging%20station%20black%20background%20by%20Blomst%20via%20Pixabay.jpg)
/Apple%20watch%20on%20wrist%20by%20fancycrave1%20via%20Pixabay.jpg)